Management of glioblastoma: State of the art and future directions
Glioblastoma is the most common malignant primary brain tumor. Overall, the prognosis for
patients with this disease is poor, with a median survival of< 2 years. There is a slight …
patients with this disease is poor, with a median survival of< 2 years. There is a slight …
Current standards of care in glioblastoma therapy
C Fernandes, A Costa, L Osório, RC Lago… - Exon …, 2017 - exonpublications.com
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults.
Regardless of ideal multidisciplinary treatment, including maximal surgical resection …
Regardless of ideal multidisciplinary treatment, including maximal surgical resection …
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
Background Standard therapy for newly diagnosed glioblastoma is radiotherapy plus
temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab …
temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab …
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Newly diagnosed glioblastoma is now commonly treated with surgery, if feasible, or biopsy,
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …
followed by radiation plus concomitant and adjuvant temozolomide. The treatment of …
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent …
K Maier-Hauff, F Ulrich, D Nestler, H Niehoff… - Journal of neuro …, 2011 - Springer
Therapy options at the time of recurrence of glioblastoma multiforme are often limited. We
investigated whether treatment with a new intratumoral thermotherapy procedure using …
investigated whether treatment with a new intratumoral thermotherapy procedure using …
Radiation, inflammation and the immune response in cancer
Radiation is an important component of cancer treatment with more than half of all patients
receive radiotherapy during their cancer experience. While the impact of radiation on tumour …
receive radiotherapy during their cancer experience. While the impact of radiation on tumour …
Radiation therapy for glioblastoma: executive summary of an American Society for Radiation Oncology evidence-based clinical practice guideline
Purpose To present evidence-based guidelines for radiation therapy in treating glioblastoma
not arising from the brainstem. Methods and materials The American Society for Radiation …
not arising from the brainstem. Methods and materials The American Society for Radiation …
Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study
S Kawabata, M Suzuki, K Hirose… - Neuro-oncology …, 2021 - academic.oup.com
Background Boron neutron capture therapy (BNCT) utilizes tumor-selective particle
radiation. This study aimed to assess the safety and efficacy of accelerator-based BNCT (AB …
radiation. This study aimed to assess the safety and efficacy of accelerator-based BNCT (AB …
[HTML][HTML] Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review
Background and purpose Both stereotactic radiotherapy (SRT) and immune-or targeted
therapy play an increasingly important role in personalized treatment of metastatic disease …
therapy play an increasingly important role in personalized treatment of metastatic disease …
Current status and recent advances in reirradiation of glioblastoma
G Minniti, M Niyazi, F Alongi, P Navarria, C Belka - Radiation Oncology, 2021 - Springer
Despite aggressive management consisting of maximal safe surgical resection followed by
external beam radiation therapy (60 Gy/30 fractions) with concomitant and adjuvant …
external beam radiation therapy (60 Gy/30 fractions) with concomitant and adjuvant …